NCT00711087 |
|
Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury H-20344
|
View
|
NCT01072591 |
|
Study to Assess MEDI -578 in Patients With Osteoarthritis OA of the Knee
|
View
|
NCT01121419 |
|
The Role of IMP3 Expression in Patients With Neuroblastoma
|
View
|
NCT01839591 |
|
Bronchial Thermoplasty Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa
|
View
|
NCT02324712 |
|
Cytokine and Growth Factor Changes and Correlation With Clinical Outcomes Following Acupuncture for TMD
|
View
|
NCT04260087 |
|
New Daily Persistent Headache Biomarkers Study
|
View
|
NCT03304457 |
|
Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
|
View
|
NCT03470038 |
|
Interaction Between NGF and Acute Exercise-induced Ischemia
|
View
|
NCT03686163 |
|
Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
|
View
|
NCT03862547 |
|
NGF TrKAp75NTR in Men With ED and Diabetes With or Without MS
|
View
|
NCT04428983 |
|
The Effect of Hericium Erinaceus Mycelium in Non-motor Symptoms of Parkinsons Disease
|
View
|
NCT04936126 |
|
Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression
|
View
|
NCT04986384 |
|
Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema
|
View
|
NCT05275647 |
|
Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis
|
View
|
NCT06143241 |
|
Cognitive Function and Glymphatic System in Children with Epilepsy
|
View
|
NCT01081184 |
|
Neurotrophins Implications in Primary Sjögren Syndrome
|
View
|
NCT05907733 |
|
Brain-derived Neurotrophic Factor BDNF Single Nucleotide Gene Polymorphism and Nerve Growth Factor as Risk Factors That Increase Severity of Allergic Rhinitis
|
View
|
NCT04307602 |
|
Long-term Exercise Effects from Robotic Walking
|
View
|
NCT06265519 |
|
Association of Urine BDNF and NGF With Lower Urinary System Parameters
|
View
|
NCT05733572 |
|
Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma OPG
|
View
|
NCT03431402 |
|
Effects of Repetitive Hyperbaric Oxygen Therapy in Patients With Acute Ischaemic Stroke
|
View
|
NCT01163825 |
|
Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimers Disease Patients
|
View
|
NCT00087789 |
|
CERE-110 in Subjects With Mild to Moderate Alzheimers Disease
|
View
|
NCT01243502 |
|
A Study to Assess the Pharmacokinetics Safety and Tolerability of CT327 in Healthy Male Volunteers
|
View
|
NCT01499069 |
|
Urinary Nerve Growth Factor NGF Prostaglandin E2 PGE2and Adenosine Triphosphate ATP Potential Biomarkers in Overactive Bladder Patients
|
View
|
NCT01499940 |
|
Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway
|
View
|
NCT00627978 |
|
Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
|
View
|
NCT01629433 |
|
Onabotulinumtoxina Intradetrusorial Injections and NGF Expression
|
View
|
NCT02032147 |
|
Treatment of Cerebral Radiation Necrosis CRN With Nerve Growth Factor NGF
|
View
|
NCT01682603 |
|
Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients
|
View
|
NCT01718015 |
|
Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy
|
View
|
NCT02138149 |
|
Is the Nerve Growth Factor NGF a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury
|
View
|
NCT02271750 |
|
IGF and Other Neurotrophic Factors in Patients With Dementia
|
View
|
NCT01735578 |
|
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
|
View
|
NCT01212679 |
|
Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury
|
View
|
NCT01243307 |
|
A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor NGF and Evoked Pain Responses in Healthy Male Volunteers
|
View
|
NCT02709486 |
|
Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
|
View
|
NCT01781117 |
|
Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
|
View
|
NCT01457573 |
|
Pilot Trial Of Urinary Nerve Growth Factor NGF As Biomarker for Male Lower Urinary Tract Symptoms
|
View
|
NCT01664962 |
|
Search for Genetic Basis of Vulvodynia
|
View
|
NCT01681784 |
|
Studies of Biomarkers in Female Lower Urinary Tract Symptoms
|
View
|
NCT01744704 |
|
Study to Evaluate Safety Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
|
View
|
NCT01800799 |
|
Urinary NGF as A Biomarker for Acute Bacterial Cystitis
|
View
|
NCT02173925 |
|
Gut Hormone Nociceptors Neurotrophic Factors Expression in Functional Dyspepsia
|
View
|
NCT02335853 |
|
Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder
|
View
|
NCT02389270 |
|
Urinary Neurotrophin Levels in Healthy Children
|
View
|
NCT02454387 |
|
A Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers
|
View
|
NCT02681861 |
|
A Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects
|
View
|
NCT02852317 |
|
Urinary Markers of Detrusor Overactivity in Spina Bifida Patients
|
View
|
NCT03033355 |
|
Central Nervous System Changes Following BotulinumtoxinA Injection in the Bladder
|
View
|
NCT03217942 |
|
Spread of Muscle Hyperalgesia and Pain in a Low Dose NGF-induced Pain Model
|
View
|
NCT06142929 |
|
Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
|
View
|
NCT03354624 |
|
Cortical Neuroplasticity by Muscle Pain of Pain-induced Plasticity
|
View
|
NCT03992170 |
|
Study of Daratumumab in Multiple Myeloma MM Patients in VGPRMRD-positive
|
View
|
NCT03676400 |
|
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
|
View
|
NCT03675100 |
|
Neurotrophic Factors Tight Junction Proteins and Cytokines in IBS
|
View
|
NCT04944251 |
|
Regular Exercise Improves Physical Capacity and Promotes Neurotrophins in Patients With Multiple Sclerosis
|
View
|
NCT04163419 |
|
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
|
View
|
NCT05700864 |
|
NGF Treatment for Patients With Neuropathic Corneal Pain
|
View
|
NCT05813145 |
|
Fenofibrate Role in Breast Cancer Patients
|
View
|
NCT05231694 |
|
The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
|
View
|
NCT06327503 |
|
Salivary Signal Molecules for Neural and Vascular Homeostasis in T2DM
|
View
|
NCT05278611 |
|
a Safety and Tolerability Study of EP-9001A in Healthy Volunteers
|
View
|
NCT06563193 |
|
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder A Case-Control Study
|
View
|
NCT06517654 |
|
Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis
|
View
|
NCT05652751 |
|
Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
|
View
|
NCT05751174 |
|
Determination of Nerve Growth Factor NGF Expression in Pediatric Patients With Severe Burns a Pilot Study
|
View
|
NCT00864097 |
|
Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
|
View
|
NCT05866757 |
|
Discontinuation Study
|
View
|
NCT00941746 |
|
Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain
|
View
|
NCT06018025 |
|
NDPH Biomarker Study in Children and Adolescents
|
View
|
NCT01157507 |
|
Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome
|
View
|
NCT01255917 |
|
Nerve Growth Factor in Chronic Pancreatitis
|
View
|
NCT06391645 |
|
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
|
View
|
NCT05502705 |
|
The Effect of Intravenous Lidocaine on Postoperative Cognitive Function in Elderly Patients
|
View
|
NCT02159170 |
|
Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor
|
View
|
NCT05390164 |
|
Sensory Symptoms in Active Vitiligo
|
View
|
NCT00830180 |
|
Open Label Extension In Cancer Patients
|
View
|
NCT01223820 |
|
Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin
|
View
|
NCT01493401 |
|
Urinary Urinary Nerve Growth Factor NGF as a Biomarker for Mixed Urinary Incontinence
|
View
|
NCT02325687 |
|
A Pilot Study of Biomarkers in Obstructive Sleep Apnea
|
View
|
NCT00225472 |
|
Organ Preservation Media Investigation
|
View
|
NCT00409942 |
|
Effect of a New Formulation of Torasemide Prolonged Releaseon Myocardial Fibrosis in Patients With Heart Failure
|
View
|
NCT00809354 |
|
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs NSAIDs Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
|
View
|
NCT00876863 |
|
Randomized Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimers Disease
|
View
|
NCT02855450 |
|
Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma
|
View
|
NCT03019627 |
|
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
|
View
|
NCT03516292 |
|
Assessment of Potential Biomarkers in Women With Symptoms of Overactive Bladder and Pelvic Organ Prolapse
|
View
|
NCT03844243 |
|
Exercise-induced Ischemia and the Influence of Pain Modulation in a Nerve Growth Factor NGF Model
|
View
|
NCT03968042 |
|
Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury
|
View
|